Laurion Capital Management LP Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $493,320 - $643,920	-1,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $336,180 - $494,430	1,000 New	1,000 $488,000
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $27 Million - $37.1 Million	-98,600 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $22.2 Million - $25.8 Million	81,100 Added 463.43%	98,600 $27.4 Million
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $1.17 Million - $1.62 Million	3,900 Added 28.68%	17,500 $5.48 Million
Q1 2019 May 08, 2019	SELL	$372.08 - $439.57 $74,416 - $87,914	-200 Reduced 1.45%	13,600 $5.58 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $11.3 Million - $13.5 Million	-33,600 Reduced 70.89%	13,800 $5.15 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $16.6 Million - $19.4 Million	47,400 New	47,400 $19.2 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.